Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Doxorubicin followed by Docetaxel-Cisplatin in LABC
NCT00538525Phase 2Completed
- Sponsor
- King Faisal Specialist Hospital and Research Centre
- Start
- Sep 2007
- Primary completion
- Apr 2008
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of doxorubicin, docetaxel, cisplatin in breast cancer, sponsored by King Faisal Specialist Hospital and Research Centre. Started Sep 2007; status: completed.
02
Drugs
doxorubicindocetaxelcisplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00538525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00538525.